LifeMD (NASDAQ: LFMD) insider transactions
In the twelve months to 10 November 2026, executives and directors of LifeMD reported 1 open-market sale of 15,000 shares ($54,150) and 0 open-market purchases, by 1 person, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 11 August 2026 | Strawn John R Jr | Director | Grant or award | +35,000 | — | 498,001 | Form 4 |
| 11 August 2026 | Larovere Joan | Director | Grant or award | +35,000 | — | 142,050 | Form 4 |
| 11 August 2026 | Macrae Calum Archibald | Director | Grant or award | +35,000 | — | 73,865 | Form 4 |
| 11 August 2026 | Simon Roberto | Director | Grant or award | +35,000 | — | 288,175 | Form 4 |
| 11 August 2026 | DiTrolio Joseph | Director | Grant or award | +35,000 | — | 308,413 | Form 4 |
| 1 June 2026 | Sripad Umesh | Chief Technology Officer | Grant or award | +75,000 | — | 75,000 | Form 4 |
| 11 May 2026 | Kavthekar Atul | Chief Financial Officer | Grant or award | +337,500 | — | 337,500 | Form 4 |
| 4 May 2026 | Strawn John R Jr | Director | Grant or award | +50,000 | — | 463,001 | Form 4 |
| 4 May 2026 | Simon Roberto | Director | Grant or award | +50,000 | — | 253,175 | Form 4 |
| 30 March 2026 | Pisano Christopher A | Chief Marketing Officer | Grant or award | +200,000 | — | 200,000 | Form 4 |
| 9 December 2025 | Friedeman Jessica | Chief Marketing Officer | Open-market sale | −15,000 | $3.61 | 205,000 | Form 4 |
| 6 October 2025 | Larovere Joan | Director | Grant or award | +22,365 | — | 107,050 | Form 4 |
| 6 October 2025 | Strawn John R Jr | Director | Grant or award | +22,365 | — | 413,001 | Form 4 |
| 2 October 2025 | Simon Roberto | Director | Grant or award | +22,365 | — | 183,175 | Form 4 |
| 2 October 2025 | Macrae Calum Archibald | Director | Grant or award | +22,365 | — | 38,865 | Form 4 |
| 2 October 2025 | DiTrolio Joseph | Director | Grant or award | +22,365 | — | 273,413 | Form 4 |
| 10 September 2025 | Alvarez Nicholas P | Chief Acquisition Officer | Open-market sale | −75,000 | $5.92 | 605,000 | Form 4 |
| 22 August 2025 | Dray Shayna Webb | Chief Operating Officer | Grant or award | +30,000 | — | 295,000 | Form 4 |
| 22 August 2025 | Alvarez Nicholas P | Chief Acquisition Officer | Grant or award | +100,000 | — | 680,000 | Form 4 |
| 22 August 2025 | Benathen Marc David | Chief Financial Officer | Grant or award | +87,000 | — | 426,554 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the LifeMD page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.